⚠️ Educational purposes only. PeptideIQ does not constitute medical advice, diagnosis, or treatment. Peptide therapy should only be pursued under the guidance of a licensed medical provider. Many peptides discussed are research-grade compounds not approved by the FDA. Always verify current legal status in your jurisdiction before use.
← Back to library
CJC-1295
CJC-1295 (with or without DAC)
ModerateResearch Grade
A long-acting growth hormone-releasing hormone (GHRH) analog that sustains elevated GH and IGF-1 levels.
Mechanism of action
GHRH receptor agonism, sustained GH secretion, IGF-1 elevation
Primary benefits
- ✓Increased muscle mass
- ✓Fat loss
- ✓Improved recovery
- ✓Better sleep quality
- ✓Anti-aging effects
Dosing
Beginner
1-2 mcg/kg body weight
Intermediate
2 mcg/kg body weight
Advanced
2-3 mcg/kg body weight
Frequency: Daily (without DAC) or 1-2x weekly (with DAC)
Timing: Pre-sleep or fasted state for maximum GH pulse
Route: Subcutaneous injection
Cycling protocol
Duration
12-16 weeks
Pattern
5 days on / 2 days off
Break after
6-8 weeks
Important warnings
- ⚠️Nominations for Category 2 withdrawn but FDA advisory review pending
- ⚠️Can increase fasting blood glucose
- ⚠️Monitor IGF-1 levels